|
| Exchange Disseminated Time 16/11/2016 11:51:06 | With reference to the earlier intimation dated October 26, 2016 about announcement of IndAS compliant financial results within the extended timelines as permitted SEBI, Suven Life Sciences Ltd has now informed BSE that a meeting of Board of Directors of the Company will be held on November 24, 2016, to consider among other things, the Un-audited Financial Results for the second quarter and half year ended September 30, 2016.
Further, TRADING WINDOW for dealing in the securities of the Company is closed from November 16, 2016 to November 27, 2016 (both days inclusive). Trading window will be opened from November 28, 2016. |
|
|